| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Sturge Simon serves as a Director at MLTX. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $2.8M at current prices.
The biggest single holding is MLTX (~$2.8M) as Director. The recent filings there lean toward selling, a net 171,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2024 | MLTX Moonlake Immunotherapeutics | Director | Sell | 171,000 | $53.72 | $9,186,120.00 | -49.9% | -3.1% | -84.8% |